Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
A Study of the Safety and Pharmacology of MetMAb (PRO143966), a Monovalent Antagonist Antibody to the Receptor C-Met, Administered Intravenously in Patients With Locally Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Pilot Study of Bevacizumab (Avastin) in Patients With Septic Shock
- Status
- WITHDRAWN
- Phase
- NA
Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
HAI Abraxane With Gemcitabine and Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Bevacizumab and Ixabepilone for Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
- Status
- TERMINATED
- Phase
- PHASE2
Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma
- Status
- TERMINATED
- Phase
- PHASE2
A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Temozolomide Plus Bevacizumab in Patients With Metastatic Melanoma Involving the Central Nervous System
- Status
- COMPLETED
- Phase
- PHASE2
RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Hypertension Monitoring in Glioma Patients Treated With Bevacizumab
- Status
- TERMINATED
- Phase
- N/A
Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Branch Retinal Vein Occlusion
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy of PreOperative Bevacizumab for Diabetic Eye Disease
- Status
- COMPLETED
- Phase
- NA
Photodynamic Therapy Alone Versus Combined With Intravitreal Bevacizumab for Age-related Macular Degeneration
- Status
- COMPLETED
- Phase
- NA
Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Long-term Results After Intravitreal Bevacizumab Treatment Of Neovascular Age-related Macular Degeneration
- Status
- COMPLETED
- Phase
- NA
Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy
- Status
- COMPLETED
- Phase
- PHASE4
Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Capecitabine and Oxaliplatin Plus Bevacizumab as Neoadjuvant Treatment for Untreated Unresectable Liver-only Metastases From Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Radiosurgery and Avastin for Recurrent Malignant Gliomas
- Status
- COMPLETED
- Phase
- NA